Debevoise & Plimpton LLP has advised Symbiotic Capital in its inaugural fundraising of more than $600 million in capital committed and targeted for investments and co-investments. For more information, read the company’s press release.

Symbiotic Capital is a global life science credit firm.

The Debevoise team was led by investment management partners Sally Bergmann Hardesty and Jonathan Adler and included counsel Fatema Al-Arayedh, associates Ali Bazzi and Huiyu Yin and tax partner Michael Bolotin.